Lachmann_Lab

The lab combines basic biology of stem cells and macrophages with translational approaches of cell therapy to develop novel forms of treatments

[Lachmann_Lab @LachmannLab]

@ALNeehus @Nature Congrats @ALNeehus and the entire team. I am so proud :)

[Lachmann_Lab @LachmannLab]

@Evotec Thanks@ @Evotec was nice to see colleagues and to discuss new #therapies and #manufacturing of #immune #cells

[Lachmann_Lab @LachmannLab]

@AViejoBorbolla @Kinchingtonp @DanDepledge @KreyLab @NatureComms @Lmendesmonteiro Thanks Abel, this was really #exciting ....CONGRATS

[Lachmann_Lab @LachmannLab]

Great work @BeziatV and colleagues

[Vivien Béziat @BeziatV]

Out in @CellCellPress today! We describe the first humans with inherited, complete FLT3L deficiency. Despite a lack of most dendritic cells, they reached adulthood. See the thread below for the main highlights of our paper. https://t.co/0jPFLfDRQh

[Lachmann_Lab @LachmannLab]

@jonas_schupp #speechless

[Lachmann_Lab @LachmannLab]

@CCRM_ca Inspiring scientist and a a sad day for the stem cell community :(.

[Lachmann_Lab @LachmannLab]

@JhKmann What a sad day for stem cell research :(

[Lachmann_Lab @LachmannLab]

@lab_mass @Wjkkol Very nice paper :)…

[Lachmann_Lab @LachmannLab]

Interested in #macrophages and #cell and #gene therapies? #Passionist for translational #science performing research from bench2bedside? We are looking for a #postdoc to join our team on macrophage-based #therapies.
https://t.co/rzVuxBwX0K

[Lachmann_Lab @LachmannLab]

@JHKlusmann @SchuelerLeah @AnnaLenaSchmell #sweet

[Lachmann_Lab @LachmannLab]

@jclinicalinvest @Kottond @BU_Tweets Nice study @Kottond :)

[Lachmann_Lab @LachmannLab]

@OlmerLab @ERC_Research Thank u soooo much :)

[Lachmann_Lab @LachmannLab]

Thankful @ERC_Research to receive funding in the #ERCPoC funding scheme and my third ERC grant to further advance our #iPSC #macrophage pipeline to deliver macrophages directly into #lungs of #patients who suffer from bacterial airway infections.
https://t.co/D4U8czTnPS

[Killian Hurley @killian_hurley]

Our #openscience paper describing our #iPSC training school is published. 31 researchers from accross europe were trained in #iPSC techniques @RCSI_Irl. Video protocols in paper.
@SchweikertAnja @LabHurley @drnadianathan @ChiaraDeSanti3 @COSTprogramme https://t.co/loiTD5V2Tu

[Lachmann_Lab @LachmannLab]

@killian_hurley @RCSI_Irl @SchweikertAnja @LabHurley @drnadianathan @ChiaraDeSanti3 @COSTprogramme Use of iPSC in modern #lung #research is of significance, differentiating #iPSC into all kind of lung different lung cells establish new #cell culture #models. #eu #networking drives #Science forward. 😃@killian_hurley thanks for being part

[Lachmann_Lab @LachmannLab]

Locked #Macrophages to enhance anti-tumor activity. #CARs can do so much and much more. Check our latest NN @NatImmunol. #cancer #immunity #cells #immunotherapy

https://t.co/BBT2zKp2Jw

[Lachmann_Lab @LachmannLab]

Fabulous study and sooo important. Thanks to the entire #family. We feel honored to have contributed to this outstanding work on #monocytes #macrophages, laying the foundation for new #treatments. congrats @BustamanteJaci1 @ALNeehus @casanova_lab and Bruce Trapnell from CCHMC.

[Casanova Lab @casanova_lab]

1/ We are excited to report the discovery and mechanistic exploration of human AR complete CCR2 deficiency in @CellCellPress. Surprisingly, CCR2 deficiency underlies two narrow phenotypes: progressive polycystic lung disease and mycobacterial disease (https://t.co/CqtZkU6Qdd).

[Lachmann_Lab @LachmannLab]

Training next gen #scientists in #stemcells science is of utmost importance. Thanks @killian_hurley @cost #training #ipsc #student

[Darrell Kotton @Kottond]

So good when you see a former graduate of @CReM_Boston spreading the Open Source gospel! Way to go @killian_hurley Lab @RCSI_Irl ! Keep sharing! #opensourcerules! #itsthecells! #helpisontheway!
https://t.co/6XpuQKUp6h

[Lachmann_Lab @LachmannLab]

@Kottond @CReM_Boston @killian_hurley @RCSI_Irl Nice experience and an honor to support @killian_hurley . Well done

[Lachmann_Lab @LachmannLab]

#macrophages from human iPSC equipped with CARs, entering next generation #immunotherapies. New therapies for anti-#cancer and beyond. See paper below @jitcancer @ShifaaAbdin

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Scalable generation of functional human iPSC-derived CAR-macrophages that efficiently eradicate CD19-positive leukemia https://t.co/Ws4Gc6sLBO @LachmannLab @ShifaaAbdin